SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-050445
Filing Date
2022-04-26
Accepted
2022-04-26 17:16:10
Documents
14
Period of Report
2022-04-26
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2213457d1_8k.htm   iXBRL 8-K 25878
2 EXHIBIT 3.1 tm2213457d1_ex3-1.htm EX-3.1 1419
6 GRAPHIC tm2213457d1_ex3-1img001.jpg GRAPHIC 254661
  Complete submission text file 0001104659-22-050445.txt   555048

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nviv-20220426.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nviv-20220426_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nviv-20220426_pre.xml EX-101.PRE 22615
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2213457d1_8k_htm.xml XML 3735
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 22855385
SIC: 3841 Surgical & Medical Instruments & Apparatus